SNWV SANUWAVE Health, Inc.

$4.47 +0.00%

Updated 16 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

SANUWAVE Health, Inc. (SNWV) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $38 million. Shares last traded at $4.47, 89.0% below their 52-week high. Over the past year the stock is down 88.5%. SNWV trades at a price-to-earnings ratio of 2.81, below the Surgical & Medical Instruments & Apparatus median of 28.18. Net profit margin is 31.3%, above the peer median of -9.3%. Revenue grew 35.0% year over year.

Market Cap

$38M

Shares Out

8.6M

EPS (TTM)

$-1.79

P/E Ratio

2.81

P/S Ratio

0.88

P/B Ratio

13.80

Dividend / Share

—

Dividend Yield

—

52-Week High

$40.67

52-Week Low

$4.40

Volume

1,482

Avg Vol (3m)

6,329.175

Performance

-4.89%

-25.13%

-70.94%

-80.72%

YTD

-84.48%

-88.47%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

29.47

SMA (50)

$6.82

SMA (200)

$18.83

Price vs SMA50

-34.42%

Price vs SMA200

-76.27%

ATR (14)

$0.38

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$44M

Net Income

$14M

Gross Margin

76.2%

Operating Margin

0.3%

Net Margin

31.3%

Return on Equity

490.7%

Return on Assets

37.4%

Current Ratio

1.28

Debt / Equity

7.36

Revenue Growth (YoY)

+35.0%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.25	2026-08-06
Q1 2026	$-0.17	2026-05-12
FY 2025	$0.41	2026-03-26
FY 2025	$0.21	2026-03-26
Q2 2026	$-0.65	2026-08-06
Q1 2026	$-0.72	2026-05-12

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

SNWV vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 16 d ago

P/E vs peers

2.81 / 28.18 med

-90% discount

P/S vs peers

0.88 / 2.94 med

-70% discount

Net margin vs peers

31.3% / -9.3% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.